Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$2.49 - $11.85 $996 - $4,740
-400 Reduced 80.0%
100 $0
Q2 2023

Jul 18, 2023

BUY
$6.39 - $28.58 $1,917 - $8,574
300 Added 150.0%
500 $0
Q1 2023

May 01, 2023

SELL
$17.7 - $33.24 $14,160 - $26,592
-800 Reduced 80.0%
200 $0
Q4 2022

Feb 07, 2023

BUY
$10.25 - $22.43 $5,125 - $11,215
500 Added 100.0%
1,000 $2,000
Q3 2022

Oct 25, 2022

BUY
$11.19 - $17.89 $2,238 - $3,578
200 Added 66.67%
500 $0
Q2 2022

Aug 04, 2022

SELL
$9.03 - $21.55 $43,344 - $103,440
-4,800 Reduced 94.12%
300 $0
Q1 2022

Apr 14, 2022

BUY
$15.0 - $22.83 $73,500 - $111,866
4,900 Added 2450.0%
5,100 $6,000
Q4 2021

Jan 18, 2022

SELL
$20.12 - $35.09 $14,084 - $24,563
-700 Reduced 77.78%
200 $0
Q2 2021

Jul 19, 2021

BUY
$29.06 - $38.83 $14,530 - $19,415
500 Added 125.0%
900 $0
Q1 2021

Apr 26, 2021

SELL
$39.04 - $64.6 $144,448 - $239,019
-3,700 Reduced 90.24%
400 $1,000
Q4 2020

Jan 21, 2021

SELL
$42.46 - $56.58 $237,776 - $316,848
-5,600 Reduced 57.73%
4,100 $9,000
Q3 2020

Oct 27, 2020

BUY
$37.44 - $64.63 $194,688 - $336,076
5,200 Added 115.56%
9,700 $46,000
Q2 2020

Jul 22, 2020

BUY
$17.62 - $58.71 $14,096 - $46,968
800 Added 21.62%
4,500 $74,000
Q1 2020

May 07, 2020

BUY
$12.26 - $41.14 $45,362 - $152,218
3,700 New
3,700 $10,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $12.9M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.